Eye mounted device for therapeutic agent release
US-12167978-B2 · Dec 17, 2024 · US
US2019366092A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2019366092-A1 |
| Application number | US-201916516066-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jul 18, 2019 |
| Priority date | Apr 28, 2006 |
| Publication date | Dec 5, 2019 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
In electrically stimulating neural tissue it is important to prevent over stimulation and unbalanced stimulation, which would cause damage to the neural tissue, the electrode, or both. It is critical that neural tissue is not subjected to any direct current or alternating current above a safe threshold. Further, it is important to identify defective electrodes, as continued use may result in neural damage and further electrode damage. The present invention presents system and stimulator control mechanisms to prevent damage to neural tissue.
Opening claim text (preview).
1 . A method of stimulating neural tissue comprising: providing a neural stimulator including a plurality of electrodes suitable to stimulate neural tissue; testing and recording the capacitance of each electrode in the plurality of electrodes; tracking changes in capacitance over time for each electrode; and determining bad electrodes based on change in capacitance. 2 . The method according to claim 1 , wherein change in capacitance is measured as a phase shift. 3 . The method according to claim 1 , further comprising disabling bad electrodes. 4 . The method according to claim 1 , further comprising an external input from a video processor. 5 . The method according to claim 1 , wherein the step of stimulating neural tissue is stimulating visual neural tissue to form artificial vision. 6 . The method according to claim 1 , wherein said step of stimulating neural tissue according to the external input includes receiving input from multiple sources. 7 . The method according to claim 1 , wherein the step of stimulating neural tissue is stimulating with charged balanced cathodic and anodic pulses. 8 . The method according to claim 7 , further comprising shorting the plurality of electrodes to ground after the anodic pulses. 9 . The method according to claim 8 , further comprising measuring leakage current on each electrode when the electrode is shorted to ground. 10 . The method according to claim 9 , further comprising disabling a driver related to an electrode within the plurality of electrodes when leakage current is detected on the electrode. 13 . The method according to claim 11 , further comprising transmitting an error signal when leakage current is detected.
Selection of the electrode configuration · CPC title
for improving safety · CPC title
Retinal electrodes · CPC title
of the eye · CPC title
Arrangements or circuits for monitoring, protecting, controlling or indicating {(for external stimulators A61N1/3603; for implantable neurostimulators A61N1/36128; for heart stimulators A61N1/37; for defibrillators A61N1/3925)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.